+49 30 648 35 164 service@chameleon-pharma.com

Pharmacy chain 36,6 has signed partnership agreement with supermarket group DIXY

36,6 is one of the key players in the Russian pharmacy market. The company specializes in retail sales of Rx and OTC products as well as drugstore equipment and cosmetics. In addition, 36,6 owns pharmacy brands such as Apteki Gorzdrav, Stary Lekar and 03 Apteka. The 36,6 chain accounts for approximately eight hundred pharmacies in twenty regions of Russia.

36,6 has recently signed an agreement with the supermarket chain DIXY to acquire priority rights to distribute their pharma products in DIXY’s supermarkets. Some of 36,6’s subsidiaries are already located in DIXY outlets in the Moscow area and throughout the capital. Moreover, the agreement allows pharmacies to be opened in the supermarket chains U doma and Victoria which are also owned by DIXY.

The DIXY Director of external relations, Ekaterina Kumanina, has said that this cooperation will give customers the opportunity to buy important medications along with grocery products close to their homes. Additionally, since 36,6 is a well-established partner, the DIXY group can rely on the quality and price of their services.

Both companies plan to expand beyond the Moscow region as well.

Other big pharmacies already have agreements with grocery retail groups. For instance, the pharmacy group A5 is planning to open approximately one thousand branches in grocery stores belonging to theX5 Retail group, which owns supermarket chains such as Perekrestok, Pyaterochka and Karusel.

Featured image : Mike Mozart – pharmacy

Contact us

1 + 1 =

Related Posts

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet CPC at expopharm Munich 2026: Explore Pharmacy and

Meet Chameleon Pharma Consulting CEO Reiner Christensen at expopharm Munich from 15–17 September 2026. Arrange an individual meeting to discuss pharmacy trends, international market entry, partner identification, and consumer healthcare opportunities.

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico’s New Fast-Track Drug & Medical Device Registration

Mexico is reshaping its COFEPRIS registration system with a new abbreviated Reliance pathway for eligible drugs and Medical Devices. With review targets of 45 business days for medicines and CPC Fast-Track registration strategies targeting approximately 10–15 months, the new framework creates important opportunities for faster market entry.

Meet Chameleon Pharma Consulting at CPHI Milan 2026

Meet Chameleon Pharma Consulting at CPHI Milan 2026

Meet Chameleon Pharma Consulting CEO Reiner Christensen at CPHI Milan from 6–8 October 2026. Schedule a meeting to discuss international market entry, licensing, partner identification, and growth opportunities for your pharma or consumer healthcare business.

Our services

i

International Company Partner Identification

Licensing and
M&A

Product Potential & Country Analysis

International Business & Market Entry

U

Pharma Regulatory & Registration

Pharma Executive
Search

International Strategy & Analysis

Market Reports and Analysis